Melanoma-associated glycosyltransferase GCNT2 as an emerging biomarker and therapeutic target. Perez M, Chakraborty A, Lau LS, Mohammed NBB, et al. Br J Dermatol 2021 Mar 3. doi: 10.1111/bjd.19891.

Read + Share

Amedeo Smart

Independent Medical Education

Perez M, Chakraborty A, Lau LS, Mohammed NBB, et al. Melanoma-associated glycosyltransferase GCNT2 as an emerging biomarker and therapeutic target. Br J Dermatol 2021 Mar 3. doi: 10.1111/bjd.19891.
PMID: 33660254